Aidite(301580)

Search documents
爱迪特(301580) - 2024年年度权益分派实施公告
2025-06-02 07:45
证券代码: 301580 证券简称:爱迪特 公告编号: 2025-018 爱迪特(秦皇岛)科技股份有限公司 2. 自分配方案披露至实施期间公司股本总额未发生变化。 3. 本次实施的分配方案与股东会审议通过的分配方案一致,未发生调整情 形。 4. 本次实施分配方案距离股东会审议通过的时间未超过两个月。 2024 年年度权益分派实施公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有 虚假记载、误导性陈述或重大遗漏。 爱迪特(秦皇岛)科技股份有限公司(以下简称"公司") 2024 年年度权 益分派方案已获 2025 年 5 月 21 日召开的 2024 年年度股东会审议通过,现将权 益分派事宜公告如下: 一、股东会审议通过利润分配方案等情况 1. 公司于 2025 年 5 月 21 日召开的 2024 年年度股东会审议通过的 2024 年年 度利润分配方案为: 以公司现有总股本 76,117,527 股为基数,向全体股东每 10 股派发现金红利 6.5元(含税),合计派发现金股利49,476,392.55 元(含税), 同时以资本公积金向全体股东每 10 股转增 4 股,合计转增 30,447,0 ...
爱迪特(301580) - 301580爱迪特投资者关系管理信息20250527
2025-05-27 09:02
Group 1: Company Advantages - Brand Strength: The company promotes its own brand overseas and establishes subsidiaries in key markets to enhance service reach [1] - R&D Capability: The company emphasizes product development, with R&D personnel accounting for 15.12% of the workforce in 2024, totaling 145 staff [1] - Product Portfolio: The company offers a diverse range of dental restoration materials, including dental crowns, implant bases, and implants, along with self-developed digital dental equipment [1] Group 2: Development Strategy - Market Insight: The company continuously analyzes market trends and customer needs to build a comprehensive product system and penetrate global markets [2] - Future Planning: The company is strategically positioning itself in implant systems, complete dentures, and 3D printing to support mid- to long-term growth [2] - Resource Integration: The company focuses on external development opportunities and aims to integrate cutting-edge technologies globally [2] Group 3: Market Drivers - Domestic Market: Digital penetration in the supply chain will standardize dental processing, driven by aging population and increased oral health awareness [2] - International Markets: Mature markets like Europe and the U.S. show steady growth with strong payment capabilities for digital products, while emerging markets present structural opportunities [2] Group 4: Material Comparison - Zirconia vs. Glass Ceramics: These materials serve different clinical needs; glass ceramics are used for aesthetic repairs, while zirconia is versatile for various restorations [2] Group 5: Overseas Sales Strategy - Subsidiary Establishment: The company has set up subsidiaries in mature markets like the U.S., Germany, South Korea, and Japan to enhance service capabilities [3] - Sales Model: A "direct sales + distribution" model is employed in the U.S. and Europe to provide comprehensive pre- and post-sales support [3] - Market Management: The company focuses on matching customer needs, strengthening brand presence, and enhancing local team capabilities to improve market share [3]
爱迪特(301580) - 301580爱迪特投资者关系管理信息20250523
2025-05-23 09:34
Group 1: Company Growth and Market Strategy - The company aims to enhance its industry position through technological innovation and digital transformation in the dental sector, focusing on external growth opportunities via investments and acquisitions [1] - The long-term outlook for the dental digital equipment business is positive, driven by factors such as aging population, rising economic levels, and increased awareness of oral care, indicating a broad market potential [2] Group 2: Revenue and Market Distribution - In the first half of 2024, domestic revenue accounted for 41.22%, highlighting the significant growth potential and policy support in the Chinese market, which serves as a foundation for global expansion [3] - The company has a balanced distribution of sales across over 100 countries and regions, including Europe, North America, Asia, South America, and Australia, which helps mitigate risks associated with reliance on a single market [3] Group 3: Production and Operational Preparedness - The company has established a production base in South Korea after acquiring a controlling stake in a local firm, primarily for the production of implant systems [4] - Ongoing automation upgrades in production lines are aimed at ensuring stable product supply and manageable operational costs for overseas production bases [4]
爱迪特(301580) - 北京市中伦律师事务所关于爱迪特(秦皇岛)科技股份有限公司2024年年度股东会的法律意见书
2025-05-21 10:52
北京市中伦律师事务所 关于爱迪特(秦皇岛)科技股份有限公司 2024 年年度股东会的 法律意见书 致:爱迪特(秦皇岛)科技股份有限公司 北京市中伦律师事务所(以下简称"本所")接受爱迪特(秦皇岛)科技股 份有限公司(以下简称"公司")的委托,指派本所律师对公司 2024 年年度股 东会(以下简称"本次股东会")的合法性进行见证并出具法律意见。 本法律意见书根据《中华人民共和国公司法》(以下简称"《公司法》")、 《中华人民共和国证券法》(以下简称"《证券法》")、《上市公司股东会规 则》(以下简称"《股东会规则》")和《深圳证券交易所上市公司自律监管指 引第 2 号——创业板上市公司规范运作》等现行有效的法律、法规、规范性文件 以及《爱迪特(秦皇岛)科技股份有限公司章程》(以下简称"《公司章程》")、 《爱迪特(秦皇岛)科技股份有限公司股东会议事规则》(以下简称"《股东会 议事规则》")的有关规定,出具本法律意见书。 为出具本法律意见书,本所律师审查了公司本次股东会的有关文件和材料。 本所律师得到公司如下保证,即其已提供了本所律师认为出具本法律意见书所必 需的材料,所提供的原始材料、副本、复印件、扫描件等材料 ...
爱迪特(301580) - 2024年年度股东会决议公告
2025-05-21 10:52
爱迪特(秦皇岛)科技股份有限公司(以下简称"公司")2024 年年度股 东会(以下简称"股东会")现场会议于 2025 年 5 月 21 日下午 14:30 在河北省 秦皇岛市经济技术开发区都山路 9 号公司二楼会议室召开;同时使用深圳证券 交易所交易系统网络投票于 2025 年 5 月 21 日交易时间接受网络投票,即 9:15- 9:25,9:30-11:30和13:00-15:00;使用深圳证券交易所互联网投票系统于2025年 5 月 21 日 9:15-15:00 期间接受网络投票。 股东出席的总体情况:出席本次股东会的股东及股东的委托代理人共计 74 人,代表公司有表决权的股份 26,051,118 股,占公司有表决权股份总数的 34.2249%。其中,参加现场会议的股东及股东代表 6 人,代表公司有表决权的 股份 25,894,418 股,占公司有表决权股份总数的 34.0190%;参加网络投票的股 东及股东代表 68 人,代表公司有表决权的股份 156,700 股,占公司有表决权股 份总数的 0.2059%。 证券代码: 301580 证券简称:爱迪特 公告编号: 2025-017 爱迪特(秦皇 ...
爱迪特(301580) - 301580爱迪特投资者关系管理信息20250520
2025-05-20 00:12
Group 1: Company Performance Outlook - The company expects its performance in 2025 to exceed that of the previous year, adjusting strategies based on market conditions [2] - In the first half of 2024, domestic revenue accounted for 41.22%, indicating significant growth potential in the Chinese market [2] - The company aims for substantial revenue growth from its acquisition of Korean Wolan in 2025, focusing on market expansion and brand building [2] Group 2: Product Pricing and Market Strategy - Product prices remain stable, with changes primarily due to sales structure and tiered pricing policies [2] - The company has a balanced distribution of sales across multiple regions, including Europe, North America, Asia, South America, and Australia, reducing reliance on any single market [2] - Most tariffs on products exported to the U.S. are borne by customers, mitigating operational risks for the company [2] Group 3: Innovations and Digital Solutions - The company is responding to the digitalization needs in orthodontics by offering comprehensive digital solutions, including 3D printing technology [4] - In 2025, the company will upgrade its milling machine series and launch a 49-minute rapid sintering furnace, alongside advancements in 3D printing products [6] - The introduction of 3D printed full dentures and precise implant solutions for edentulous patients marks a significant innovation in the company's offerings [8] Group 4: Overseas Market Development - The company emphasizes matching customer needs in overseas markets and enhancing brand presence through training and relationship building [7] - Following the acquisition of Korean Wolan, the company is exploring the feasibility of establishing production bases in Europe and Asia [10] - The company is actively investing in channel development and market penetration to seize opportunities in the growing dental implant sector [9]
爱迪特(301580) - 中信建投证券股份有限公司关于爱迪特(秦皇岛)科技股份有限公司2024年度持续督导跟踪报告
2025-05-15 09:04
中信建投证券股份有限公司 关于爱迪特(秦皇岛)科技股份有限公司 2024 年度持续督导跟踪报告 | 保荐人名称:中信建投证券股份有限公司 | 上市公司简称:爱迪特 | | --- | --- | | 保荐代表人姓名:张铁 | 联系电话:021-68801592 | | 保荐代表人姓名:周俊峰 | 联系电话:010-86451688 | 二、保荐人发现公司存在的问题及采取的措施 | 事 项 | 存在的问题 | 采取的措施 | | --- | --- | --- | | 1.信息披露 | 无 | 不适用 | | 2.公司内部制度的建立和执行 | 无 | 不适用 | | 3."三会"运作 | 无 | 不适用 | | 4.控股股东及实际控制人变动 | 无 | 不适用 | | 5.募集资金存放及使用 | 无 | 不适用 | | 6.关联交易 | 无 | 不适用 | | 7.对外担保 | 无 | 不适用 | | 8.收购、出售资产 | 无 | 不适用 | | 9.其他业务类别重要事项(包括 对外投资、风险投资、委托理财、 | 无 | 不适用 | | 财务资助、套期保值等) | | | | 10.发行人或者其聘请的中介机 ...
爱迪特24年度营收、净利齐创新高 拟10转4派6.5元
Quan Jing Wang· 2025-04-30 09:38
Core Viewpoint - The company, Aidi Te (301580.SZ), is experiencing rapid business growth in the dental restoration materials and digital dental equipment sector, leveraging digitalization to connect clinical and technical aspects of dental services, while focusing on consumer needs [1][2]. Group 1: Financial Performance - In 2024, Aidi Te achieved a revenue of 888 million yuan, a year-on-year increase of 13.81% [1]. - The net profit attributable to shareholders was 150 million yuan, up 2.40% from the previous year, while the net profit after deducting non-recurring gains and losses was 145 million yuan, reflecting a growth of 9.32% [1]. - The company plans to distribute a cash dividend of 0.49 million yuan (including tax) and a capital reserve conversion of 30.45 million shares, with a cash dividend ratio of 32.88% of the annual net profit [1]. Group 2: Research and Development - Aidi Te invested 47.36 million yuan in R&D during the reporting period, marking an 18.21% increase year-on-year [2]. - The company has developed a comprehensive product R&D system covering various aspects of the dental industry, including new dental restoration materials and digital equipment [2]. - The synergy between the digital equipment and restoration materials enhances market competitiveness and promotes digital transformation in the traditional dental industry [2]. Group 3: Market Position and Growth Outlook - Aidi Te has established a strong presence in the domestic dental medical industry, with its products distributed across major provinces and cities in China, and has also made significant inroads into international markets [2]. - The company is expected to maintain a growth trajectory due to its leading position in dental restoration materials and digital equipment, supported by robust R&D and a global sales network [2]. - In Q1 2025, Aidi Te reported a revenue of 205 million yuan, an 18.07% increase year-on-year, and a net profit of 31.27 million yuan, reflecting a substantial growth of 34.21% [3]. - The company aims to enhance its growth-oriented business and improve operational efficiency through strategic planning and market expansion in 2025 [3].
爱迪特(301580) - 301580爱迪特投资者关系管理信息20250429
2025-04-29 11:50
Group 1: Market Performance - The overseas market experienced a year-on-year growth of 19.88% in 2024, achieving a revenue of 518 million [1] - The company has 16 years of experience in overseas market expansion, covering over 100 countries and regions [1] - The demand for digital equipment in the denture processing industry is slowing down in China, the US, and Europe, while the chairside market still holds significant potential [2] Group 2: Product Development and Sales - The company completed the acquisition of Korean Wolan in May 2024, with expected revenue of over 18 million in the second half of 2024 [2] - The narrow-neck implant and digital surgical tool kit from Wolan are expected to receive NMPA certification this year, with the ALL-ON-X occlusion reconstruction plan set to launch soon [3] - Sales of zirconia products are maintaining a medium to high growth rate, with stable prices and improved gross margins [6] Group 3: International Strategy and Risk Management - The European market accounts for the highest share of overseas revenue, followed by the Americas, with notable growth in the Middle East and Asia [4] - The US tariff policy has a controllable impact on the company's exports, with 38.15% of revenue coming from the domestic market, providing growth space and policy support [4] - The company plans to increase inventory at its US subsidiary to mitigate short-term impacts from tariffs [5] Group 4: Client Strategy and Market Expansion - In 2024, the company achieved significant results in large client cooperation, increasing the procurement budget share from major clients [6] - The company aims to build a global ecosystem of large and quality clients, promoting industry progress [6] - The company is enhancing brand building for Wolan and providing diverse training courses to strengthen market promotion [3] Group 5: Future Growth and Value Creation - The company expects stable growth in overseas business due to product quality, technological innovation, and customer service advantages [8] - The company focuses on core business development and technological innovation to enhance market competitiveness and profitability [9] - A stable cash dividend policy and improved investor relations management are part of the company's value realization strategy [9]
爱迪特(301580) - 内部控制审计报告
2025-04-28 18:44
RSM 容诚 内部控制审计报告 爱迪特(秦皇岛)科技股份有限公司 容诚审字|2025|215Z0179号 容诚会i 容诚会计师事务所(特殊普通合伙) 中国 · 北京 您可使用手机"扫一扫"或进入"注册会计师行业统一监管平台(http://ac.mof.gov.cn)"进行查 您可使用手机"扫一扫"或进入"注册会计师行业统一监管平台(http://ac.mof.gov.cn) "进行查 " " " " 内部控制审计报告 容诚审字[2025]215Z0179号 爱迪特(秦皇岛)科技股份有限公司全体股东: 按照《企业内部控制审计指引》及中国注册会计师执业准则的相关要求,我 们审计了爱迪特(秦皇岛)科技股份有限公司(以下简称"爱迪特公司")2024年 12 月 31 日的财务报告内部控制的有效性。 一、企业对内部控制的责任 按照《企业内部控制基本规范》、《企业内部控制应用指引》、《企业内部 控制评价指引》的规定,建立健全和有效实施内部控制,并评价其有效性是爱迪 特公司董事会的责任。 二、注册会计师的责任 我们的责任是在实施审计工作的基础上,对财务报告内部控制的有效性发表 审计意见,并对注意到的非财务报告内部控制的重大 ...